Trial
NCT00799435
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Diabetes Mellitus, Type 2
Intervention
Exenatide
Why stopped
Inability to recruit adequate Sample Size who met the entry criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-04